CN103611091B - A kind of Chinese medicine composition for the treatment of cancer of pancreas - Google Patents

A kind of Chinese medicine composition for the treatment of cancer of pancreas Download PDF

Info

Publication number
CN103611091B
CN103611091B CN201310669009.7A CN201310669009A CN103611091B CN 103611091 B CN103611091 B CN 103611091B CN 201310669009 A CN201310669009 A CN 201310669009A CN 103611091 B CN103611091 B CN 103611091B
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
rhizoma
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310669009.7A
Other languages
Chinese (zh)
Other versions
CN103611091A (en
Inventor
王启凌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dongguan Dongzhuo Zhongtian Biotechnology Co Ltd
Original Assignee
Dongguan Dongzhuo Zhongtian Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongguan Dongzhuo Zhongtian Biotechnology Co Ltd filed Critical Dongguan Dongzhuo Zhongtian Biotechnology Co Ltd
Priority to CN201310669009.7A priority Critical patent/CN103611091B/en
Publication of CN103611091A publication Critical patent/CN103611091A/en
Application granted granted Critical
Publication of CN103611091B publication Critical patent/CN103611091B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of Chinese medicine composition for the treatment of cancer of pancreas, providing a kind of take Chinese crude drug as the medicine of the treatment cancer of pancreas of waste, and its curative effect is high, symptom alleviates obviously, improves patients ' life quality and survival rate.The crude drug of Chinese medicine composition of the present invention is made up of following component: Semen Ziziphi Spinosae, the Radix Astragali, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Semen Coicis core, Herba Hedyotidis Diffusae, Poria, Fructus Akebiae, Herba Scutellariae Barbatae, Herba Salviae Chinensis, Radix Polygalae, Radix Glycyrrhizae, Radix Bupleuri, Rhizoma Cyperi, Radix Curcumae, Fructus Citri Sarcodactylis, Herba Lobeliae Chinensis, Rhizoma Corydalis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, the Rhizoma Pinelliae, Cortex Magnoliae Officinalis, Flos Calystegiae sepii, the Radix Paeoniae Alba, the Pseudobulbus Bletillae (Rhizoma Bletillae).The present invention is mainly used in the treatment of cancer of pancreas, has rapid-action, good effect, the features such as taking convenience, and compares with general chemicals and have the little feature of toxic and side effects, and its anticancer effect is obvious.

Description

A kind of Chinese medicine composition for the treatment of cancer of pancreas
Technical field
The invention belongs to Chinese medicine composition, be specifically related to a kind of Chinese medicine composition of the treatment cancer of pancreas be made up of the multiple Chinese herbal medicine with anticancer function.
Background technology
Cancer of pancreas is one of common malignant tumor, and the M & M of nearly many decades cancer of pancreas has the trend obviously increased, and the M & M of cancer of pancreas rises rapidly, and this is a worldwide trend.The method of current treatment cancer of pancreas has operation, chemotherapy, chemotherapy and radiotherapy.Surgical operation is one of most important means of cancer of pancreas Comprehensive Treatment always, and this method is mainly used in topical therapeutic, especially for early stage Small pancreatic carcinoma, and Patients with Subclinical Small pancreatic carcinoma.Although technology and the mode for the treatment of of pancreatic cancer make rapid progress, to the limited use improving survival rate, still unavoidably recur, because cancer is genopathy.Radiotherapy is for relatively early, and don't to tolerate operative treatment or tumor length in some treatments that are special, that be difficult to the position of excising are a kind of well Part Substitution treatment meanss.Chemotherapy is a kind of method killed for potential metastatic lesion of whole body therapeutic, but due to the toxic and side effects of chemotherapeutics large, therefore the immunity of people often eliminates by this Therapeutic Method.
Cancer of pancreas is regarded as a topical manifestations of systemic disease by the traditional Chinese medical science, treatment is emphasized across-the-board regulation function of human body, passes through determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs.Chinese medicine energy Combined with Radiotherapy, chemotherapy attenuation synergistic, can accelerate postoperative rehabilitation, relieving the pain caused by diseases after surgery, improves life quality.
Summary of the invention
The object of the invention is the defect existed to overcome prior art, for the deficiency that existing clinical antineoplastic is treated, thering is provided a kind of take Chinese crude drug as the medicine of the treatment cancer of pancreas of waste, and its curative effect is high, symptom alleviates obviously, can improve patients ' life quality and extend the time-to-live.
In order to realize object of the present invention, the present invention adopts following scheme:
Treat a Chinese medicine composition for cancer of pancreas, the crude drug of its Chinese medicine is made up of the component of following weight parts proportioning:
Semen Ziziphi Spinosae 240 ~ 270 parts, the Radix Astragali 100 ~ 115 parts, Radix Codonopsis 100 ~ 115 parts, the Rhizoma Atractylodis Macrocephalae 65 ~ 80 parts, Semen Coicis core 100 ~ 115 parts, Herba Hedyotidis Diffusae 100 ~ 115 parts, 75 ~ 85 parts, Poria, Fructus Akebiae 75 ~ 85 parts, Herba Scutellariae Barbatae 95 ~ 110 parts, Herba Salviae Chinensis 75 ~ 85 parts, Radix Polygalae 60 ~ 75 parts, 20 ~ 25 parts, Radix Glycyrrhizae, Radix Bupleuri 120 ~ 145 parts, Rhizoma Cyperi 40 ~ 55 parts, Radix Curcumae 40 ~ 55 parts, Fructus Citri Sarcodactylis 45 ~ 60 parts, Herba Lobeliae Chinensis 70 ~ 85 parts, Rhizoma Corydalis 45 ~ 60 parts, Rhizoma Chuanxiong 25 ~ 30 parts, Pericarpium Citri Reticulatae 14 ~ 19 parts, the Rhizoma Pinelliae 100 ~ 115 parts, Cortex Magnoliae Officinalis 8 ~ 13 parts, Flos Calystegiae sepii 60 ~ 75 parts, the Radix Paeoniae Alba 28 ~ 35 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 65 ~ 80 parts.
Wherein in some embodiments, the crude drug of described Chinese medicine is made up of the component of following weight parts proportioning:
Semen Ziziphi Spinosae 260 parts, the Radix Astragali 105 parts, Radix Codonopsis 105 parts, the Rhizoma Atractylodis Macrocephalae 70 parts, Semen Coicis core 105 parts, Herba Hedyotidis Diffusae 105 parts, 84 parts, Poria, Fructus Akebiae 84 parts, Herba Scutellariae Barbatae 105 parts, Herba Salviae Chinensis 84 parts, Radix Polygalae 70 parts, 21 parts, Radix Glycyrrhizae, Radix Bupleuri 130 parts, Rhizoma Cyperi 50 parts, Radix Curcumae 50 parts, Fructus Citri Sarcodactylis 50 parts, Herba Lobeliae Chinensis 75 parts, Rhizoma Corydalis 50 parts, Rhizoma Chuanxiong 30 parts, Pericarpium Citri Reticulatae 16 parts, the Rhizoma Pinelliae 110 parts, Cortex Magnoliae Officinalis 10 parts, Flos Calystegiae sepii 70 parts, the Radix Paeoniae Alba 30 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 70 parts.
Semen Ziziphi Spinosae: sweet is flat;
Cure mainly: restlessness of asrhenia type and insomnia; Palpitation with fear palpitation with a distress feeling; Body empty spontaneous perspiration, night sweat.
The Radix Astragali: slightly warm in nature, sweet in the mouth.
Cure mainly: deficient qi and blood, spontaneous perspiration, chronic diarrhea proctoptosis, uterine prolapse, nephritis edema, albuminuria, diabetes, chronic ulcer.
Radix Codonopsis: sweet in the mouth, micro-acid is flat;
Cure mainly: invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.For deficiency of the spleen and lung, cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency is coughed, and interior-heat is quenched one's thirst.
The Rhizoma Atractylodis Macrocephalae: bitter, sweet, temperature;
Cure mainly: spleen reinforcing, stomach reinforcing, dampness, and in, antiabortive.Control deficient QI of the spleen and stomach, anorexia, asthenia weak breath, deficiency-distension, has loose bowels, phlegm retention, edema, jaundice, arthralgia chiefly caused by damp pathogen, dysuria, dizzy, spontaneous perspiration, and nausea is uneasy.
Semen Coicis core: sweet, be slightly cold;
Cure mainly: main arthralgia chiefly caused by damp pathogen, sharp the intestines and stomach, consumer edema, diuresis and anticancer, beriberi edema, carcinoma initial stage.
Herba Hedyotidis Diffusae: bitter, light, cold in nature;
Cure mainly: heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness.
Poria: sweet in the mouth is light flat;
Cure mainly: mind tranquilizing and the heart calming, relieve internal heat anticancer.Dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, malignant histocytosis can be controlled, have loose bowels, pass out semen, stranguria with turbid discharge, palpitation with fear, the disease such as forgetful.
Fructus Akebiae: bitter in the mouth, cold nature;
Cure mainly: the digestive system tumor such as hepatocarcinoma, gastric cancer, and pulmonary carcinoma, breast carcinoma etc.
Herba Scutellariae Barbatae: acrid in the mouth; Hardship, cold in nature;
Cure mainly: pyretic toxicity carbuncle; Have sore throat; Lung abscess; Intestinal carbuncle; Scrofula; Venom; Traumatic injury; Spit blood; Epistaxis; Stranguria with blood; Edema; Ascites and cancer.
Herba Salviae Chinensis: micro-hardship is flat;
Cure mainly: heat-clearing and toxic substances removing, invigorating blood circulation analgesia.For icterohepatitis, cancer, nephritis, leucorrhea, dysmenorrhea, tuberculous lymphadenitis, elephantiasis.
Radix Polygalae: bitter in the mouth, pungent;
Cure mainly: the function of have Fructus Alpiniae Oxyphyllae of calming the nerves, eliminate the phlegm, subsiding a swelling, the insomnia and dreamful sleep caused for disarmony between the heart and kidney, forgetful palpitation with fear, staring spells, expectoration is not well, sore swollen toxin, breast swell and pain.
Radix Glycyrrhizae: feeble QI, taste is sweet, and property is gentle;
Cure mainly: QI invigorating invigorating middle warmer; Relieving spasm to stop pain; Nourishing the lung to arrest cough; Eliminating fire and detoxication; Coordinating the actions of various ingredients in a prescription.
Radix Bupleuri: cold nature, bitter in the mouth;
Cure mainly: induce sweat bring down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, cure mainly alternate attack of chill and fever, disease such as the breast side of body feeling of distension and oppression, malaria, menoxenia etc.
Rhizoma Cyperi: pungent micro-hardship is sweet, flat;
Cure mainly: stagnation of QI due to depression of the liver, breast, the side of body, abdominal distention, dyspepsia, menoxenia, amenorrhea dysmenorrhea, colic of cold type is suffered from abdominal pain, distending pain of the breast.
Radix Curcumae: pungent, bitter, cold;
Cure mainly: promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, clear away heart-fire removing heat from blood, promoting the function of the gallbladder to alleviate jaundice.For amenorrhea dysmenorrhea, chest and abdomen swelling and pain, twinge, calentura coma, epilepsy is gone mad, jaundice dark coloured urine.
Fructus Citri Sarcodactylis: pungent, bitter, sour, temperature;
Cure mainly: liver-smoothing, qi-regulating, and stomach and alleviating pain.For stagnation of liver-QI and stomach-QI, distending pain in the chest and hypochondrium, gastral cavilty feeling of fullness, lack of appetite is vomitted.
Herba Scutellariae Barbatae: acrid in the mouth; Hardship, cold in nature;
Cure mainly: pyretic toxicity carbuncle; Have sore throat; Lung abscess; Intestinal carbuncle; Scrofula; Venom; Traumatic injury; Spit blood; Epistaxis; Stranguria with blood; Edema; Ascites and cancer.
Rhizoma Corydalis: warm in nature, acrid in the mouth is bitter;
Cure mainly: regulate the flow of vital energy, invigorate blood circulation, pain relieving.For the stomachache of qi depression to blood stasis, hypochondriac pain, headache and dysmenorrhea etc.
Rhizoma Chuanxiong: pungent, temperature;
Cure mainly: blood-activating and qi-promoting, wind-expelling pain-stopping.
Pericarpium Citri Reticulatae: warm in nature, acrid in the mouth, bitter in the mouth;
Cure mainly: regulating qi-flowing for strengthening spleen, in tune, dampness, reduces phlegm.Cure mainly distension and fullness in the abdomen or pain, the dyspepsia of stagnation of QI in spleen and stomach.Abdominal distention uncomfortable in chest in turbid damp resistance, indigestion and loss of appetite loose stool.Phlegm-damp stops up the cough and asthma of lung.For fullness in the epigastrium and chest, lack of appetite and vomiting, cough with copious phlegm.
The Rhizoma Pinelliae: acrid in the mouth, warm in nature;
Cure mainly: drying dampness to eliminate phlegm, stomach function regulating preventing or arresting vomiting, cure mainly phlegm-damp diseases caused by retention of fluid, vomiting, the diseases such as cough with asthma.
Flos Calystegiae sepii: (flower) is sweet, (root) is pungent, warm;
Cure mainly pathogenic cold in abdomen pathogenic heat gas (with root), melanotic nevus on the face.Also diuresis, reuniting the fractured tendons and bones, closes knife injury, controls erysipelas, mends strain, beneficial vital essence:
The Radix Paeoniae Alba: picric acid is cool;
Cure mainly: nourishing blood to suppress the hyperactive liver, pain relieving in slow, yin fluid astringing receives antiperspirant.Control the breast abdomen pain over the hypochondriac region, dysentery is suffered from abdominal pain, spontaneous sweating, fever due to yin deficiency.
The Pseudobulbus Bletillae (Rhizoma Bletillae): bitter in the mouth, sweet, puckery, cold nature;
Cure mainly: astringing to arrest bleeding, detumescence and promoting granulation.Spit blood for hemoptysis, traumatic hemorrhage, sore swollen toxin, chapped skin; Pulmonary tuberculosis hemoptysis, ulcer haemorrhage.
Wherein in some embodiments, described Chinese medicine composition can be prepared as a kind of pharmaceutically acceptable preparation (carrier or excipient) through extracting, mixing; The preparation of described Chinese medicine composition, it is above-mentioned Chinese medicine composition and other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
Wherein in some embodiments, the mixture of effective ingredient after extracting of described Chinese medicine composition, is prepared as a kind of pharmaceutically acceptable preparation (carrier or excipient); The preparation of described Chinese medicine composition, it is the extract of above-mentioned Chinese medicine composition and other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
A kind of medicine for the treatment of cancer of pancreas of the present invention, be made up of the multiple Chinese herbal medicine with anticancer function, through with other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, be mainly used in the treatment of cancer of pancreas, there is rapid-action, good effect, the features such as taking convenience, and compare with general chemicals there is the little feature of toxic and side effects.Its anticancer effect, except showing effective anticancer, the immunity of patient can also be strengthened, improve hemorheology index, suppress oncogene expression, cancer cell specific induction of apoptosis, anticancer is bred, and can reduce patient's injury that normal structure is subject to when accepting the treatment means such as chemotherapy, radiotherapy, reduces the incidence rate of complication for patients, thus improve the cure rate of Pancreas cancer patients, reduce the mortality rate of cancer of pancreas.
Detailed description of the invention
For feature of the present invention, technological means and the specific purposes reached, function can be understood further, resolve the advantages and spirit of the present invention, by embodiment below, the present invention is described further, embodiment only for explaining that explanation is used, never means that it limits the scope of the invention by any way.
The Chinese medicine composition dosage with obvious antitumor action provided by the invention suitably can adjust according to changes such as the orders of severity of route of administration, patient individual difference, clinical application and disease, and the crude drug of Chinese medicine is made up of the component of following weight parts proportioning:
Semen Ziziphi Spinosae 260 parts, the Radix Astragali 105 parts, Radix Codonopsis 105 parts, the Rhizoma Atractylodis Macrocephalae 70 parts, Semen Coicis core 105 parts, Herba Hedyotidis Diffusae 105 parts, 84 parts, Poria, Fructus Akebiae 84 parts, Herba Scutellariae Barbatae 105 parts, Herba Salviae Chinensis 84 parts, Radix Polygalae 70 parts, 21 parts, Radix Glycyrrhizae, Radix Bupleuri 130 parts, Rhizoma Cyperi 50 parts, Radix Curcumae 50 parts, Fructus Citri Sarcodactylis 50 parts, Herba Lobeliae Chinensis 75 parts, Rhizoma Corydalis 50 parts, Rhizoma Chuanxiong 30 parts, Pericarpium Citri Reticulatae 16 parts, the Rhizoma Pinelliae 110 parts, Cortex Magnoliae Officinalis 10 parts, Flos Calystegiae sepii 70 parts, the Radix Paeoniae Alba 30 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 70 parts.
Crude drug is mixed with by Chinese crude drug or its extract obtains through pulverizing extraction, and obtained pharmaceutical preparation is tablet, capsule, granule, pill etc.
Instructions about how to take medicine: warm water takes.One day 3 times, one time 6, a 0.3g ~ 1g, observed by the long-term follow of out-patient 10 example, transference cure, the no longer medication of 8 examples, cure rate is up to 80%.
Successful case:
Mr. Chen, 70 years old, in December, 2009 was suffered from abdominal pain more than March, and CT is diagnosed as cancer of pancreas.
More than 6 hours on an empty stomach, intravenous injection developer is row whole body (basis cranii is to femur upper segment) PET-CT tomography after 1 hour.
Examination scope development is clear, and contrast is good.
Right lobe of thyroid gland density is owed evenly, and has patch shape calcification shadow, metabolism no abnormality seen, left side pharyngeal tonsillar and throat muscle courseware symmetry developer dense poly-, SUVmax value is 5.5.Cervical region has no enlarged lymph node shadow and Developmental and Metabolic Disorder is enlivened.In right lung, inferior lobe has little similar round and little strip high density shadow, and the calcification of large portion, left lung ligule also has similar change, and in mediastinum, aortic pulmonic window has small lymph node shadow, and metabolism is inactive.
The visible similar round watery density shadow of liver lobus sinister medial segment, diameter is 1.8cm.The slight active region of gastric antrum portion visible patch shape metabolism, is thought of as inflammatory lesion.
Pancreatic body afterbody increases, Density inhomogeneity, and profile is not whole and to the extension of pancreas rear, demarcate with neighbouring part blood vessel and owe clear, pathological changes Developmental and Metabolic Disorder is enlivened, and SUVmax value is 5.6, and the visible less many lymph nodes shadow of respective regions posterior peritoneum, metabolism is comparatively active.
Patient was from 2010 06 month, and after half a year of taking medicine, epigastrium not bitterly, is not told, and stomach, can normal diet continual cure also without uncomfortable.
Mr. Zhu, 66 years old, the endoscopic endoscopic retrograde cholangiopancreatography (ERCP) of in May, 2012 CEA, CA19-9 (ERCP), through liver puncture cholangiography (PTC).
There is colic symptoms in patient, intermittent dull pain is uncomfortable, radiates with back part before 3 years, non-undulatory property, there is whole body jaundice in exacerbation of symptoms before half a year, stool as kaolin, urine as black tea, whole skin pruritus, not pursue progress food, abdominal pain and distension increases the weight of, general weakness, goes to see a doctor, plan is examined as cancer of pancreas, rear to hospital's row stones in intrahepatic bile duct PTBD.Sb.'s illness took a favorable turn, be in hospital and leave hospital January, done CT examination finding before first quarter moon: Diseases In Pancreatic Head is shown in the Density inhomogeneity soft-tissue density block shadow of cross section about 80 × 70mm, in the strengthening of obvious heterogeneity height after strengthening, main pancreatic duct is expanded, anal region is shown in the blood vessel of tortuous expansion, the lower slightly density of many places obscurity boundary is seen in liver, in weak strengthening after strengthening, the strengthening without exception of part lesion boundary, abdominal cavity is without hydrops, and intraperitoneal is shown in drainage catheter shadow.
Diagnosis: cancer of pancreas.
Patient is from October, 2012, and after half a year of taking medicine, CT examination display 40 × 60mm, in also taking medicine at present, the state of an illness has clear improvement! Mr. Li, 69 years old, in November, 2012, the bimester of near, there was swollen sense in upper abdomen department, do not have appetite, health is empty, starts constipation, and stool was normal in the past, general power from head to foot, the rotten to the corn gastritis of shallow looked into by gastroscope, did gastroscope, B ultrasonic, electrocardiogram, electrocardio color ultrasound, blood test tumor full figure.Tumor full figure has looked into a severe overweight: blood CA-199, PET-CF ultrasonic endoscope ten punctures.
Big belly, uncomfortable, anorexia, becomes thin, swollen portion hydrops.
Diseases In Pancreatic Head is shown in that cross section is about 5 × 7cm, Density inhomogeneity, soft-tissue density's block shadow, in the strengthening of obvious heterogeneity height after strengthening.
Patient is from December, 2012, and after patient consumes half a year, sb.'s illness took a favorable turn, can normally be engaged in agriculture, and does not need to take that other is medicinal, drug withdrawal.
Mr. Li, 59 years old, 2012-10-19 capable PET ﹣ CT examination: uncinate process of pancreas Bu Jian soft-tissue density lump shadow, size is 2.1 × 1.1cm about, and CT value about 5HU, PET video picture is shown in that abnormal radioactivity is dense poly-, SUVmax10.5, pancreatic tail atrophy.Ductus pancreaticus is obviously expanded, and sees that several lymph node radioactivity assembles shadow around head of pancreas.A nodositas slightly low-density shadow is respectively seen in the right front leaf of liver and right lobe of liver fornix portion, and size is respectively 1.0cm and 1.1cm(right lobe of liver neoplasm metastasis).Two lung locality edema due to disorder of QI, multiple little patch tuberosity shadow in right lung, in low metabolism.Several lymph node slightly hypermetabolism shadow in two hilus pulumonis mediastinum.
Patient is from November, 2012, and after taking medicine three months, sb.'s illness took a favorable turn, returns to one's perfect health, and checks after three months to hospital, without recurrence, does not need to have taken medicine.
The Chinese medicine composition dosage with obvious antitumor action provided by the invention suitably can adjust according to changes such as the orders of severity of route of administration, patient individual difference, clinical application and disease, its every daily dose counts 5g ~ 50g by crude drug, preferably every daily dose is 15g ~ 30g, can once or several times use.
The above embodiment only have expressed several embodiment of the present invention, and it describes comparatively concrete and detailed, but therefore can not be interpreted as the restriction to the scope of the claims of the present invention.It should be pointed out that for the person of ordinary skill of the art, without departing from the inventive concept of the premise, can also make some distortion and improvement, these all belong to protection scope of the present invention.Therefore, the protection domain of patent of the present invention should be as the criterion with claims.

Claims (4)

1. treat a Chinese medicine composition for cancer of pancreas, it is characterized in that, the crude drug of its Chinese medicine is made up of the component of following weight parts proportioning:
Semen Ziziphi Spinosae 240 ~ 270 parts, the Radix Astragali 100 ~ 115 parts, Radix Codonopsis 100 ~ 115 parts, the Rhizoma Atractylodis Macrocephalae 65 ~ 80 parts, Semen Coicis core 100 ~ 115 parts, Herba Hedyotidis Diffusae 100 ~ 115 parts, 75 ~ 85 parts, Poria, Fructus Akebiae 75 ~ 85 parts, Herba Scutellariae Barbatae 95 ~ 110 parts, Herba Salviae Chinensis 75 ~ 85 parts, Radix Polygalae 60 ~ 75 parts, 20 ~ 25 parts, Radix Glycyrrhizae, Radix Bupleuri 120 ~ 145 parts, Rhizoma Cyperi 40 ~ 55 parts, Radix Curcumae 40 ~ 55 parts, Fructus Citri Sarcodactylis 45 ~ 60 parts, Herba Lobeliae Chinensis 70 ~ 85 parts, Rhizoma Corydalis 45 ~ 60 parts, Rhizoma Chuanxiong 25 ~ 30 parts, Pericarpium Citri Reticulatae 14 ~ 19 parts, the Rhizoma Pinelliae 100 ~ 115 parts, Cortex Magnoliae Officinalis 8 ~ 13 parts, Flos Calystegiae sepii 60 ~ 75 parts, the Radix Paeoniae Alba 28 ~ 35 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 65 ~ 80 parts.
2. a kind of Chinese medicine composition for the treatment of cancer of pancreas according to claim 1, is characterized in that, the crude drug of described Chinese medicine is made up of the component of following weight parts proportioning:
Semen Ziziphi Spinosae 260 parts, the Radix Astragali 105 parts, Radix Codonopsis 105 parts, the Rhizoma Atractylodis Macrocephalae 70 parts, Semen Coicis core 105 parts, Herba Hedyotidis Diffusae 105 parts, 84 parts, Poria, Fructus Akebiae 84 parts, Herba Scutellariae Barbatae 105 parts, Herba Salviae Chinensis 84 parts, Radix Polygalae 70 parts, 21 parts, Radix Glycyrrhizae, Radix Bupleuri 130 parts, Rhizoma Cyperi 50 parts, Radix Curcumae 50 parts, Fructus Citri Sarcodactylis 50 parts, Herba Lobeliae Chinensis 75 parts, Rhizoma Corydalis 50 parts, Rhizoma Chuanxiong 30 parts, Pericarpium Citri Reticulatae 16 parts, the Rhizoma Pinelliae 110 parts, Cortex Magnoliae Officinalis 10 parts, Flos Calystegiae sepii 70 parts, the Radix Paeoniae Alba 30 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 70 parts.
3. a kind of Chinese medicine composition for the treatment of cancer of pancreas according to claim 1, is characterized in that, described Chinese medicine composition is through extracting, being mixed with as the pharmaceutically acceptable preparation of one; The preparation of described Chinese medicine composition, it is above-mentioned Chinese medicine composition and other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, and its dosage form is said following dosage form on pharmaceutics: tablet, capsule, granule, pill, powder, unguentum, suspensoid, oral liquid or injection.
4. a kind of Chinese medicine composition for the treatment of cancer of pancreas according to claim 1, is characterized in that, the mixture of effective ingredient after extracting of described Chinese medicine composition, is prepared as a kind of pharmaceutically acceptable preparation; The preparation of described Chinese medicine composition, it is the extract of above-mentioned Chinese medicine composition and other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, and its dosage form is said following dosage form on pharmaceutics: tablet, capsule, granule, pill, powder, unguentum, suspensoid, oral liquid or injection.
CN201310669009.7A 2013-12-11 2013-12-11 A kind of Chinese medicine composition for the treatment of cancer of pancreas Active CN103611091B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310669009.7A CN103611091B (en) 2013-12-11 2013-12-11 A kind of Chinese medicine composition for the treatment of cancer of pancreas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310669009.7A CN103611091B (en) 2013-12-11 2013-12-11 A kind of Chinese medicine composition for the treatment of cancer of pancreas

Publications (2)

Publication Number Publication Date
CN103611091A CN103611091A (en) 2014-03-05
CN103611091B true CN103611091B (en) 2016-04-27

Family

ID=50161824

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310669009.7A Active CN103611091B (en) 2013-12-11 2013-12-11 A kind of Chinese medicine composition for the treatment of cancer of pancreas

Country Status (1)

Country Link
CN (1) CN103611091B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104707110A (en) * 2015-04-09 2015-06-17 张妮 Traditional Chinese medicine preparation for treating pancreatic cancer and preparation method thereof
CN104958474A (en) * 2015-07-01 2015-10-07 张晓艳 Traditional Chinese medicine for treating damp heat stagnation type pancreatic cancer and preparation method thereof
CN104958594A (en) * 2015-07-02 2015-10-07 张云 Traditional Chinese medicine for qi and blood stasis stagnation type pancreatic cancer and preparation method thereof
CN105362606A (en) * 2015-12-24 2016-03-02 张云 Traditional Chinese medicine for treating liver depression and heat accumulation type pancreatic cancer in combination with chemical therapy and preparation method of traditional Chinese medicine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1772262A (en) * 2005-10-27 2006-05-17 吴军杰 Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process
CN101670071A (en) * 2009-09-25 2010-03-17 卢速江 Traditional Chinese medicine preparation for treating cancer and preparation method thereof
CN102008685A (en) * 2010-11-23 2011-04-13 高学哲 Chinese medicinal powder for treating liver cancer, lung cancer and pancreatic cancer
CN102641477A (en) * 2012-05-14 2012-08-22 许俊斋 Medicament for treating pancreatic cancer
CN102772745A (en) * 2012-08-21 2012-11-14 卢速江 Chinese medicinal preparation for treating cancer and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1772262A (en) * 2005-10-27 2006-05-17 吴军杰 Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process
CN101670071A (en) * 2009-09-25 2010-03-17 卢速江 Traditional Chinese medicine preparation for treating cancer and preparation method thereof
CN102008685A (en) * 2010-11-23 2011-04-13 高学哲 Chinese medicinal powder for treating liver cancer, lung cancer and pancreatic cancer
CN102641477A (en) * 2012-05-14 2012-08-22 许俊斋 Medicament for treating pancreatic cancer
CN102772745A (en) * 2012-08-21 2012-11-14 卢速江 Chinese medicinal preparation for treating cancer and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
晚期胰腺癌治验1例;何光鉴,陈仕凯;《成都中医药大学学报》;19951228;第18卷(第04期);第34-35页 *

Also Published As

Publication number Publication date
CN103611091A (en) 2014-03-05

Similar Documents

Publication Publication Date Title
CN103611091B (en) A kind of Chinese medicine composition for the treatment of cancer of pancreas
CN102526498B (en) Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof
CN103550696B (en) Medicine for treating lung cancer
CN103432559A (en) Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof
CN103463554B (en) A kind of treat malignant tumor pharmaceutical composition and preparation method and purposes
CN103386024B (en) Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof
CN104984267A (en) Traditional Chinese medicine composition for treating lung cancer
CN103432412B (en) Medicament for treating hyperplasia of mammary glands and preparation method thereof
CN103263587B (en) Traditional Chinese medicine preparation for treating toxic and side effects of nasopharyngeal carcinoma after radiotherapy and preparation method thereof
CN103028077B (en) Traditional Chinese medicine preparation for treating tumors
CN104288745A (en) Traditional Chinese medicine for treating CG (Chronic Gastritis)
CN104623384A (en) Liver smoothing and qi regulating drug for treating mammary gland hyperplasia and preparation method of liver smoothing and qi regulating drug
CN110339276A (en) Traditional Chinese medicine for treating digestive tract tumor and preparation method thereof
CN103920114A (en) Traditional Chinese medicinal composition for treating pulmonary fibrosis
CN104042766A (en) Traditional Chinese medicinal composition for treating habitual constipation
CN105999092A (en) Traditional Chinese medicine pill for treating melanosis coli
CN102178866A (en) Chinese medicinal preparation for dispelling damp, promoting blood circulation, softening hard mass and eliminating stagnation for people with qi-depression and blood-stagnation physique, preparation method thereof and application thereof
CN105214067A (en) A kind of medicine for the treatment of cancer patients diarrhoea
CN104623605A (en) Traditional Chinese medicine capable of treating breast cancer
CN104491364B (en) A kind of pill and preparation method for treating chronic lymphocytic thyroiditis
CN103127398B (en) Chinese medicament for treating cancers and preparation method thereof
CN102716341B (en) Traditional Chinese medicinal composition for treating acute peptic ulcer bleeding and preparation method thereof
CN102406913A (en) Chinese medicinal composition for treating melancholia
CN102120022A (en) Medicament for treating pain and fever caused by cancer
CN106822779A (en) A kind of Chinese medicine composition of the obstruction of qi in the chest and palpitation and insomnia for treating caused by energy stagnation and blood stasis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 523000 Guangdong province Dongguan City Wanjiang District Joint Village Second Industrial Zone No. 6 4 floor

Applicant after: DONGGUAN DONGZHUO ZHONGTIAN BIOTECHNOLOGY CO., LTD.

Address before: 523050 Guangdong province Dongguan City Wanjiang District Joint Village Second Industrial Zone No. 6 4 floor (Gary office building 4 floor) Dongguan Shenghong Biotechnology Co. Ltd.

Applicant before: DONGGUAN SHENGHONG BIOTECHNOLOGY CO., LTD.

COR Change of bibliographic data
C14 Grant of patent or utility model
GR01 Patent grant